How Much Will Those Allergan Inc. (AGN) Cost Cuts Really Help?
7/22/2014 6:27:10 AM
For weeks, Wall Street has been expecting Allergan to cut costs as one way to fend off the unwanted $53 billion takeover bid from Valeant Pharmaceuticals and activist investor William Ackman.
And today, Allergan took that step. The drug maker, which is famous for selling Botox, is slashing 13% of its workforce, or roughly 1,500 jobs, and will also leave 250 unfilled jobs vacant in a bid to save $475 million. The cuts do not include R&D programs and nearly all – 94%, specifically – of employees who deal directly with customers, such as doctors and hospitals, will remain in place.
Help employers find you! Check out all the jobs and post your resume.
comments powered by